resveratrol has been researched along with Diabetic Glomerulosclerosis in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (4.76) | 29.6817 |
| 2010's | 24 (57.14) | 24.3611 |
| 2020's | 16 (38.10) | 2.80 |
| Authors | Studies |
|---|---|
| Aarabi, MH; Asemi, Z; Mafi, A; Salami, M; Salami, R; Vakili, O | 1 |
| Geng, J; Gu, W; Guan, Y; Hou, X; Li, X; Song, G; Wang, C; Wang, X; Zhao, H; Zheng, K | 1 |
| Chi, Y; Liang, Y; Liu, S; Wang, H; Wang, Y; Wu, X; Zhu, B | 1 |
| Geng, J; Gu, W; Guan, Y; Hou, X; Li, X; Song, G; Wang, C; Wang, X; Yang, L; Zheng, K | 1 |
| Chen, L; Chen, S; Jiang, H; Li, B | 1 |
| Chen, L; Li, Y; Wang, K; Yan, H; Zhong, S; Zhou, M; Zhu, H | 1 |
| Chen, YB; Du, L; Gu, XK; Hao, M; Jiang, YF; Li, CC; Li, XZ; Li, Y; Lu, Q; Wang, B; Wang, J; Wang, L; Yang, H; Yin, XX | 1 |
| Nanjappan, S; Paul, D; Sapkal, R; Surendran, S | 1 |
| Chi, J; Gao, Y; Hu, J; Lv, W; Ma, X; Wang, W; Wang, Y; Xian, Y | 1 |
| Fan, YJ; Zhao, YH | 1 |
| Du, L; He, LL; Li, CC; Li, XZ; Li, Y; Liu, YQ; Lu, Q; Ma, P; Qian, X; Shu, FL; Xu, L; Yin, XX | 1 |
| Chen, F; Cheng, KW; Gowd, V; Kang, Q; Wang, Q | 1 |
| Li, R; Ma, S; Qin, G; Wang, F; Zhao, L | 1 |
| Ding, MR; Dong, XJ; Lin, X; Wang, GD; Wang, Y; Wu, MJ; Xu, GF; You, CY; Zhang, J | 1 |
| Ji, MJ; Li, KX; Sun, HJ | 1 |
| Abharzanjani, F; Hemmati, M | 1 |
| Chen, S; Ding, DF; Dong, CL; Feng, YM; Huang, SS; Lu, X; Lu, YB; Miao, H; Xu, JR; Ye, XL; You, N; You, Q; Yuan, YG | 1 |
| Cui, W; Du, B; Luo, P; Min, X; Xu, X | 1 |
| Chang, J; Du, LL; Fang, Z; Lin, SH; Liu, XM; Yuan, D | 1 |
| Omrani, GR; Roozbeh, J; Sattarinezhad, A; Shams, M; Shirazi Yeganeh, B | 1 |
| Huang, CY; Li, J; Liang, D; Liao, SC; Peng, X; Su, H; Ting, WJ | 1 |
| Gao, HQ; Guo, L; Hu, Z; Jiang, B; Li, BY; Peng, T; Song, J; Yang, XD; Zhen, JH | 1 |
| Chen, J; Gu, Y; Hao, CM; Huang, X; Wen, D; Zhang, L; Zhang, M | 1 |
| Ji, H; Ma, X; Qin, G; Wu, L | 1 |
| Ates, B; Elbe, H; Esrefoglu, M; Taskapan, C; Vardi, N; Yologlu, S | 1 |
| Ciddi, V; Dodda, D | 1 |
| Guan, X; He, T; Wang, J; Wang, S; Xiao, T; Xu, X; Yang, K; Zhao, J | 1 |
| Aktaş, A; Atamer, Y; Deveci, E; Ezel, T; Kocyigit, Y; Sermet, A; Uysal, E; Yavuz, D | 1 |
| Chen, Z; Duan, Z; Fu, R; Gao, J; Han, J; Jia, L; Lu, J; Lv, Z; Ma, L; Tian, L; Wang, L | 1 |
| Chang, YS; Choi, BS; Choi, SR; Chung, S; Hong, YA; Kim, HW; Kim, MY; Kim, Y; Kim, YS; Lim, JH; Park, CW; Park, HS | 1 |
| Hussein, MM; Mahfouz, MK | 1 |
| Guan, X; He, T; Huang, Y; Liu, L; Nie, L; Sharma, K; Wang, J; Xiao, T; Xiong, J; Xu, X; Yang, K; Yu, Y; Zhang, D; Zhang, J; Zhao, J | 1 |
| Guan, G; Liu, G; Liu, H; Meng, L; Wang, X; Wang, Z; Zhao, L | 1 |
| Ding, DF; Hu, AP; Jiang, XQ; Liu, C; Lu, YB; Miao, H; Wu, XM; Xu, JR; Ye, XL; You, N; Zhu, Q | 1 |
| Imaizumi, N; Kitada, M; Koya, D; Kume, S | 1 |
| Chen, JK; Chen, KH; Hsu, HH; Hung, CC; Jing, YH; Yang, CW | 1 |
| Palsamy, P; Subramanian, S | 1 |
| Chang, CC; Chang, CY; Huang, JP; Hung, LM; Wu, YT; Yen, TH | 1 |
| Ma, X; Qin, G; Wu, L; Zhang, N; Zhang, Y | 1 |
| Chang, YS; Choi, BS; Chung, S; Hong, YA; Kim, HW; Kim, MY; Kim, YS; Ko, SH; Koh, SH; Lee, JH; Lim, JH; Park, CW; Park, HS; Shin, SJ; Yang, KS; Youn, HH | 1 |
| Anjaneyulu, M; Chopra, K; Kulkarni, SK; Sharma, S | 1 |
| Gaikwad, A; Kabra, D; Sharma, V; Singh, K; Tikoo, K | 1 |
3 review(s) available for resveratrol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling.
Topics: Antioxidants; Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Oxidative Stress; Polyphenols; Resveratrol | 2022 |
An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy.
Topics: Animals; Diabetic Nephropathies; Humans; Resveratrol | 2021 |
Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.
Topics: Animals; Anticarcinogenic Agents; Antioxidant Response Elements; Antioxidants; Curcumin; Cysteine Proteinase Inhibitors; Diabetic Nephropathies; Enzyme Inhibitors; Humans; Isothiocyanates; Leupeptins; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol; Rutin; Signal Transduction; Stilbenes; Sulfoxides; Trace Elements; Zinc | 2017 |
1 trial(s) available for resveratrol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial.
Topics: Adult; Aged; Albuminuria; Antioxidants; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Oxidative Stress; Resveratrol; Treatment Outcome | 2019 |
38 other study(ies) available for resveratrol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway.
Topics: Animals; Antioxidants; Blood Glucose; Cell Adhesion Molecules; Diabetic Nephropathies; Kidney; Lipid Metabolism; Lipids; Mice; Mice, Inbred C57BL; Resveratrol; Signal Transduction; Sirtuin 1; Tissue Distribution | 2022 |
Knowledge-Based Discovery of the Role and Mechanism of Resveratrol in Improving Glomerular Tether Cell Proliferation and Apoptosis in Diabetic Nephropathy.
Topics: Animals; Apoptosis; Cell Proliferation; Cross-Sectional Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Knowledge Discovery; Resveratrol; Streptozocin | 2022 |
Pterostilbene, a Resveratrol Derivative, Improves Ectopic Lipid Deposition in the Kidneys of Mice Induced by a High-Fat Diet.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Fibrosis; Kidney; Lipids; Mice; Resveratrol; Stilbenes; Transforming Growth Factor beta1 | 2022 |
Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation.
Topics: Aldehyde Reductase; Diabetes Mellitus; Diabetic Nephropathies; Humans; Matrix Metalloproteinase 9; Molecular Docking Simulation; Network Pharmacology; PPAR gamma; Reproducibility of Results; Resveratrol | 2023 |
Resveratrol reverts Streptozotocin-induced diabetic nephropathy.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Autophagy-Related Protein-1 Homolog; Diabetic Nephropathies; Kidney; Lipids; Male; Nephrons; Organ Size; PPAR alpha; Rats, Sprague-Dawley; Resveratrol; Sterol Regulatory Element Binding Protein 1; Streptozocin; TOR Serine-Threonine Kinases | 2020 |
A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Kelch-Like ECH-Associated Protein 1; Ketones; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Morpholines; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol; Signal Transduction; Structure-Activity Relationship | 2020 |
Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: An in vitro and in vivo approach.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Inflammation; Memory Disorders; Mice; Mice, Inbred NOD; Resveratrol | 2020 |
Resveratrol improves lipid metabolism in diabetic nephropathy rats.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Autophagy; Diabetic Nephropathies; Disease Models, Animal; Enzyme Activation; Humans; Insulin Resistance; Lipid Metabolism; Male; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Streptozocin; TOR Serine-Threonine Kinases | 2020 |
Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Fibrosis; Gene Knockdown Techniques; Glucose; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mice; Resveratrol; Sirtuin 1; YY1 Transcription Factor | 2021 |
Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.
Topics: Diabetic Nephropathies; Endoplasmic Reticulum Stress; Glycation End Products, Advanced; Humans; Oxidative Stress; Resveratrol | 2020 |
Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Apoptosis; Caspase 3; Cells, Cultured; Diabetic Nephropathies; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Podocytes; Reactive Oxygen Species; Resveratrol | 2020 |
Resveratrol decreases high glucose‑induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress.
Topics: Administration, Oral; Animals; Antioxidants; Apoptosis; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Endoplasmic Reticulum Stress; Glucose; Kidney Tubules; Male; Mice; Rats; Resveratrol; Treatment Outcome | 2020 |
Protective effects of Quercetin and Resveratrol on aging markers in kidney under high glucose condition: in vivo and in vitro analysis.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Calcium-Binding Proteins; Carboxylic Ester Hydrolases; Cellular Senescence; Diabetic Nephropathies; Disease Models, Animal; Glucose; HEK293 Cells; Humans; Immunohistochemistry; Kidney; Oxidative Stress; Pyruvaldehyde; Quercetin; Rats; Resveratrol | 2021 |
Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.
Topics: Albuminuria; Animals; Apoptosis; Autophagy; Diabetic Nephropathies; Disease Models, Animal; Mice; Mice, Inbred C57BL; Podocytes; Protective Agents; Resveratrol; RNA, Small Interfering; Stilbenes | 2017 |
Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Kidney; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Streptozocin | 2018 |
Ramipril and resveratrol co-treatment attenuates RhoA/ROCK pathway-regulated early-stage diabetic nephropathy-associated glomerulosclerosis in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Kidney; Male; Ramipril; Rats; Rats, Sprague-Dawley; Resveratrol; rho-Associated Kinases; rhoA GTP-Binding Protein; Severity of Illness Index; Signal Transduction; Streptozocin | 2019 |
Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione s-transferases Mu in diabetic rats.
Topics: Animals; Diabetic Nephropathies; Down-Regulation; Glucose; Glutathione Transferase; Humans; Kidney; Male; Mesangial Cells; NF-E2-Related Factor 2; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2013 |
Resveratrol attenuates diabetic nephropathy via modulating angiogenesis.
Topics: Angiogenesis Modulating Agents; Angiopoietin-2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Mice; Rats; Rats, Sprague-Dawley; Receptor, TIE-2; Resveratrol; Sirtuin 1; Stilbenes; Vascular Endothelial Growth Factor A | 2013 |
The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy.
Topics: Animals; Body Weight; Collagen Type IV; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Forkhead Transcription Factors; Gene Expression Regulation; Glucose; Kidney; Lipid Peroxidation; Male; Mesangial Cells; Nerve Tissue Proteins; Oxidative Stress; Rats; Receptors, Adiponectin; Resveratrol; Stilbenes | 2014 |
Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.
Topics: Animals; Antioxidants; Blood Glucose; Blood Urea Nitrogen; Catalase; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione; Kidney; Male; Malondialdehyde; Melatonin; Quercetin; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2015 |
Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies.
Topics: Aldehyde Reductase; Animals; Cataract; Cattle; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Imidazolidines; Inhibitory Concentration 50; Kidney Function Tests; Lens, Crystalline; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2014 |
Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway.
Topics: Antioxidants; Cell Line; Diabetic Nephropathies; Drug Evaluation, Preclinical; Epithelial Cells; Epithelial-Mesenchymal Transition; Glucose; Humans; Kidney; Kidney Tubules; MAP Kinase Signaling System; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Resveratrol; Stilbenes | 2015 |
Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gliclazide; Hypoglycemic Agents; Immunohistochemistry; Kidney; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2015 |
Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat.
Topics: Animals; Antioxidants; Autophagy; Blotting, Western; Cell Hypoxia; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gene Knockdown Techniques; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Stilbenes | 2016 |
Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Apoptosis; bcl-2-Associated X Protein; Collagen Type IV; Deoxyguanosine; Diabetic Nephropathies; Fatty Acids; Fluorescent Antibody Technique; Forkhead Transcription Factors; In Situ Nick-End Labeling; Kidney; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phenotype; Phosphorylation; PPAR alpha; Receptors, Adiponectin; Resveratrol; Signal Transduction; Sirtuin 1; Sterol Regulatory Element Binding Protein 1; Stilbenes; Transforming Growth Factor beta1; Triglycerides | 2016 |
Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Expression Regulation; Glycated Hemoglobin; Kidney; Male; Nerve Tissue Proteins; NF-kappa B; Oxidative Stress; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; Rosuvastatin Calcium; Sirtuin 1; Stilbenes; Transforming Growth Factor beta1 | 2016 |
Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cell Differentiation; Cell Line; Cell Proliferation; Diabetic Nephropathies; Fibroblasts; Fibrosis; Gene Expression Regulation; Glucose; Kidney; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myofibroblasts; NADPH Oxidase 4; Rats; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes | 2016 |
Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway.
Topics: Animals; Catalase; Cytoprotection; Diabetic Nephropathies; Forkhead Box Protein O3; Hyperglycemia; Kidney Tubules; Male; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2017 |
Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Diabetic Nephropathies; Hypertrophy; Kidney; Male; Phosphorylation; Protein Kinases; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2010 |
Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Immunohistochemistry; Immunoprecipitation; Kidney; Male; Mice; Oxidative Stress; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2011 |
Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
Topics: Animals; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Hypoglycemic Agents; Kidney; Male; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Smad Proteins; Stilbenes; Transforming Growth Factor beta | 2011 |
Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling.
Topics: Animals; Antioxidants; Base Sequence; Cytokines; Diabetic Nephropathies; DNA Primers; Hyperglycemia; Inflammation Mediators; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Kidney; Male; Microscopy, Electron, Transmission; NF-E2-Related Factor 2; Oxidative Stress; Polymerase Chain Reaction; Proteins; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2011 |
Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.
Topics: AMP-Activated Protein Kinases; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Gene Expression; Male; Oxidative Stress; Rats; Rats, Long-Evans; Resveratrol; Stilbenes | 2011 |
The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats.
Topics: Animals; Antioxidants; Body Weight; Catalase; Collagen Type IV; Diabetic Nephropathies; Fibronectins; Forkhead Transcription Factors; Gene Expression Regulation; Kidney; Male; Nerve Tissue Proteins; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Stilbenes | 2012 |
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Activation; Kidney; Lipid Metabolism; Lipotropic Agents; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidative Stress; Protective Agents; Protein Processing, Post-Translational; Resveratrol; RNA Interference; Signal Transduction; Sirtuin 1; Stilbenes; Transcription Factors | 2013 |
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glutathione; Kidney; Kidney Function Tests; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Phenols; Phytoalexins; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Stilbenes; Superoxide Dismutase; Terpenes | 2006 |
Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Histones; Male; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Streptozocin; Tumor Suppressor Protein p53 | 2008 |